Related Experiment Videos

Neutrophil activation after percutaneous transluminal coronary angioplasty

H Ikeda1, H Nakayama, T Oda

  • 1Third Department of Internal Medicine, Kurume University School of Medicine, Japan.

American Heart Journal
|December 1, 1994
PubMed

Insights

Percutaneous transluminal coronary angioplasty (PTCA) activates neutrophils, indicated by increased CD11b expression and elastase. This suggests neutrophils may play a role in the ischemic injury following PTCA procedures.

Area of Science:

  • Cardiology
  • Immunology
  • Biochemistry

Background:

  • Coronary artery disease (CAD) affects millions globally.
  • Percutaneous transluminal coronary angioplasty (PTCA) is a common intervention for CAD.
  • The role of neutrophils in PTCA-induced injury is not fully understood.

Purpose of the Study:

  • To investigate whether PTCA induces neutrophil activation in patients with coronary artery disease.
  • To assess specific markers of neutrophil activation following PTCA.

Main Methods:

  • Blood samples were collected from the coronary sinus of patients undergoing PTCA and coronary arteriography (CAG).
  • Flow cytometry was used to measure CD11b expression and hydrogen peroxide generation in neutrophils.
  • Neutrophil elastase levels were measured using an immunoenzymatic method.

Main Results:

  • PTCA significantly increased CD11b surface expression on neutrophils (approximately twofold).
  • PTCA led to a significant decrease in stimulated neutrophil hydrogen peroxide generation, suggesting prior in vivo activation.
  • Neutrophil elastase levels significantly increased after PTCA compared to CAG.

Conclusions:

  • PTCA induces significant neutrophil activation in patients with coronary artery disease.
  • Activated neutrophils may contribute to the ischemic injury associated with PTCA.
  • Further research is warranted to explore therapeutic strategies targeting neutrophil activation post-PTCA.

Related Concept Videos